IL6 and non-small cell lung carcinoma: In NSCLC cells which harbor mutant EGFR overactivate STAT3, but this activation is not direct driven by EGFR since this process requires the upregulation of the IL-6 via the gp130/JAK pathway12, 27, 40, 44, 49.